PR002306 (Project)

Description:Cystic fibrosis (CF) pharmacological correctors such as VX-445 are used in combinations as highly effective modulator therapy (HEMT) at CF clinics due to their efficacy in improving Cystic Fibrosis transmembrane conductance regulator (CFTR) protein trafficking and function. We utilized LC-MS/MS to identify crosslinked proteins in CF bronchial epithelial cells expressing F508del CFTR, identifying SCCPDH, an uncharacterized putative oxidoreductase, as a VX-445 specific off-target. We then characterized changes in the metabolomic profiles of cells overexpressing SCCPDH to decipher its role and implications of VX-445 binding to SCCPDH-dependent metabolic changes. We found dysregulation of amino acid metabolism and a potential inhibitory activity of VX-445 on SCCPDH. The identified off-target may explain exacerbation of psychological symptoms observed in patients on HEMT, thus emphasizing the need for further optimization of corrector combinations.
Results found

Linked to

 

Label

Description

 

Project

Metabolomics

Subject

A subject from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project

Biosample

A biosample from Metabolomics produced as part of the PR002306 project


  • Subject

    A subject from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project


  • Biosample

    A biosample from Metabolomics produced as part of the PR002306 project

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.